HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Selmi Selected Research

Immunoglobulin A (IgA)

1/2020Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population.
12/2019The clinical implications of selective IgA deficiency.
3/2016Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects.
3/2009Apotopes and the biliary specificity of primary biliary cirrhosis.
6/2007The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo Selmi Research Topics

Disease

52Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 01/2002
37Autoimmune Diseases (Autoimmune Disease)
05/2022 - 07/2003
27Inflammation (Inflammations)
06/2022 - 01/2006
26Rheumatoid Arthritis
01/2022 - 10/2010
18Neoplasms (Cancer)
10/2022 - 08/2004
17Infections
03/2022 - 04/2005
13Psoriatic Arthritis
11/2021 - 04/2014
12Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2021 - 05/2006
11Liver Diseases (Liver Disease)
05/2022 - 06/2007
11Systemic Scleroderma (Systemic Sclerosis)
01/2022 - 12/2005
10Myositis (Idiopathic Inflammatory Myopathies)
10/2022 - 08/2015
10Arthritis (Polyarthritis)
01/2021 - 04/2014
9COVID-19
03/2022 - 01/2020
8Dermatomyositis (Dermatopolymyositis)
10/2022 - 08/2013
7Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 11/2014
7Rheumatic Diseases (Rheumatism)
01/2020 - 03/2009
7Fibrosis (Cirrhosis)
10/2015 - 06/2005
6Liver Cirrhosis (Hepatic Cirrhosis)
01/2016 - 10/2003
5Polymyositis
01/2022 - 02/2017
5Virus Diseases (Viral Diseases)
11/2021 - 05/2006
5Obesity
01/2015 - 02/2008
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2015 - 03/2010
5Non-alcoholic Fatty Liver Disease
03/2014 - 02/2008
4Connective Tissue Diseases (Connective Tissue Disease)
01/2022 - 12/2017
4Disease Progression
10/2021 - 09/2007
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
03/2021 - 08/2012
4Vasculitis (Vasculitides)
03/2021 - 02/2010
4Sjogren's Syndrome (Sjogren Syndrome)
02/2021 - 06/2015
4Ankylosing Spondylitis
01/2021 - 04/2014
4Atherosclerosis
01/2020 - 02/2013
4Antisynthetase syndrome
11/2019 - 08/2015
4Cryoglobulinemia
07/2019 - 05/2009
4Multiple Sclerosis
08/2017 - 10/2010
4Hypersensitivity (Allergy)
12/2014 - 03/2010
3Cholestasis
01/2022 - 10/2003
3Thrombosis (Thrombus)
12/2021 - 01/2020
3Necrosis
11/2021 - 05/2010
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2021 - 08/2012
3Hepatitis B
01/2021 - 03/2015
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021 - 08/2012
3Genetic Predisposition to Disease (Genetic Predisposition)
01/2019 - 01/2011
3Psoriasis (Pustulosis Palmaris et Plantaris)
12/2018 - 06/2014
3Disease Susceptibility (Diathesis)
09/2017 - 10/2003
3Reactive Arthritis (Reiter Disease)
09/2015 - 04/2014
3Cholangitis
02/2015 - 10/2010
3Body Weight (Weight, Body)
01/2015 - 03/2010
3Chronic Hepatitis C
09/2009 - 05/2006
2Skin Manifestations
10/2022 - 11/2014

Drug/Important Bio-Agent (IBA)

50AutoantibodiesIBA
10/2022 - 03/2005
42AntibodiesIBA
10/2022 - 11/2004
16Biomarkers (Surrogate Marker)IBA
01/2021 - 05/2006
14AntigensIBA
06/2022 - 08/2004
13CytokinesIBA
06/2022 - 06/2005
12Proteins (Proteins, Gene)FDA Link
10/2022 - 11/2004
11AutoantigensIBA
11/2021 - 03/2005
8Biological ProductsIBA
05/2022 - 03/2015
8Immunoglobulin G (IgG)IBA
03/2022 - 09/2009
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 05/2010
7Immunoglobulin M (IgM)IBA
01/2018 - 04/2005
7Sodium Glutamate (Accent)IBA
01/2015 - 02/2008
6MicroRNAs (MicroRNA)IBA
11/2021 - 08/2014
6Etanercept (Enbrel)FDA Link
03/2021 - 12/2014
6Pharmaceutical PreparationsIBA
01/2020 - 09/2006
6XenobioticsIBA
01/2010 - 11/2003
5Methotrexate (Mexate)FDA LinkGeneric
05/2022 - 11/2010
5tocilizumab (atlizumab)FDA Link
02/2021 - 12/2014
5InterferonsIBA
02/2021 - 05/2006
5Immunoglobulin A (IgA)IBA
01/2020 - 06/2007
4Ligases (Synthetase)IBA
10/2022 - 08/2013
4Oxidoreductases (Dehydrogenase)IBA
01/2022 - 06/2006
4Pyruvic Acid (Pyruvate)IBA
01/2022 - 06/2006
4Antiviral Agents (Antivirals)IBA
01/2022 - 09/2009
4Antinuclear AntibodiesIBA
11/2021 - 08/2005
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
03/2021 - 12/2015
4SteroidsIBA
01/2021 - 09/2015
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2020 - 06/2011
4Adrenal Cortex Hormones (Corticosteroids)IBA
02/2017 - 03/2013
4Vitamin DFDA LinkGeneric
02/2015 - 03/2010
3VaccinesIBA
03/2022 - 03/2010
3Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2022 - 03/2009
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2021 - 01/2021
3Janus KinasesIBA
07/2021 - 12/2014
3Immunoglobulins (Immunoglobulin)IBA
05/2021 - 01/2009
3Interleukin-23 (Interleukin 23)IBA
01/2021 - 09/2018
3Rheumatoid FactorIBA
01/2021 - 01/2018
3Interleukin-17 (Interleukin 17)IBA
01/2021 - 06/2015
3Monoclonal AntibodiesIBA
01/2021 - 03/2009
3Phospholipids (Phosphatides)FDA LinkGeneric
01/2020 - 05/2012
3apremilastIBA
01/2020 - 12/2018
3Anti-Bacterial Agents (Antibiotics)IBA
12/2019 - 12/2012
3Abatacept (Orencia)FDA Link
01/2019 - 08/2014
3EpitopesIBA
06/2018 - 04/2010
3Hormones (Hormone)IBA
12/2017 - 06/2005
3LipidsIBA
08/2017 - 03/2008
3Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2016 - 05/2009
3HLA-B27 Antigen (HLA B27 Antigen)IBA
05/2015 - 04/2014
2RNA (Ribonucleic Acid)IBA
10/2022 - 02/2017

Therapy/Procedure

19Therapeutics
01/2021 - 03/2006
4Biological Therapy
01/2020 - 03/2014
3Liver Transplantation
07/2011 - 11/2010